Used primarily in pharmaceutical research as a potent serotonin receptor modulator, particularly targeting 5-HT1A and 5-HT2A subtypes. It shows promise in the development of treatments for neurological and psychiatric disorders such as depression, anxiety, and schizophrenia due to its high affinity and selectivity for these receptors. Its structural configuration supports strong blood-brain barrier penetration, making it suitable for central nervous system-targeted therapies. Additionally, it serves as a key intermediate in synthesizing analogs for structure-activity relationship studies in neuropharmacology.